| Model 1 - MMAS-8 | Model 2 - PDC | ||||
---|---|---|---|---|---|---|
β | 95% CI | p | β | 95% CI | p | |
Financial Burden | −0.29 | −0.48 - -0.11 | 0.002 | −2.76 | −5.65 - 0.14 | 0.062 |
Age | − 0.15 | − 0.46 - 0.16 | 0.341 | 1.28 | −1.74 - 4.31 | 0.401 |
Male | − 0.19 | − 0.36 - -0.03 | 0.019 | − 0.68 | −3.14 - 1.78 | 0.585 |
Education | ||||||
 Secondary | −0.06 | − 0.23 - 0.12 | 0.513 | −1.02 | −3.70 - 1.65 | 0.449 |
 Third-Level | 0.02 | −0.22 - 0.26 | 0.872 | −2.94 | −7.38 - 1.50 | 0.191 |
Marital Status | ||||||
 Single/Divorced/Widow | −0.07 | − 0.25 - 0.11 | 0.421 | 0.17 | −1.86 - 2.20 | 0.866 |
 Private Health Insurance | 0.01 | −0.15 - 0.17 | 0.896 | 1.42 | −0.79 - 3.64 | 0.205 |
 Current Smoker | −0.25 | −0.56 - 0.07 | 0.123 | −1.84 | −6.48 - 2.80 | 0.432 |
 Heart Attack | −0.18 | −0.44 - 0.08 | 0.169 | 1.06 | −1.99 - 4.11 | 0.492 |
 Angina | 0.09 | −0.19 - 0.37 | 0.532 | 0.06 | −2.12 - 2.24 | 0.958 |
 Stroke | 0.15 | −0.33 - 0.64 | 0.530 | −0.89 | −7.50 - 5.71 | 0.789 |
 No. of comorbidities | −0.05 | −0.12 - 0.01 | 0.123 | 0.07 | −0.57 - 0.72 | 0.829 |
 No. of regular medicines | 0.04 | 0.01–0.07 | 0.007 | 0.53 | 0.17–0.89 | 0.005 |
 Use of MDUs | −0.32 | −0.63 - -0.01 | 0.041 | −0.14 | −2.97 - 2.68 | 0.920 |
 AHT Dosing Frequency | 0.07 | −0.09 - 0.23 | 0.397 | −0.68 | −3.20 - 1.84 | 0.594 |
 AHT WHO-DDD | 0.02 | −0.03 - 0.06 | 0.451 | 0.01 | −0.45 - 0.47 | 0.975 |
 Angiotensin acting agents | −0.01 | −0.24 - 0.22 | 0.955 | −0.45 | −3.46 - 2.55 | 0.764 |
 Alpha-blockers | −0.17 | −0.60 - 0.25 | 0.418 | −0.40 | −4.04 - 3.24 | 0.828 |
 Beta-blockers | −0.07 | −0.26 - 0.12 | 0.451 | 1.13 | −0.97 - 3.23 | 0.287 |
 Calcium Channel Blockers | −0.01 | −0.18 - 0.15 | 0.868 | 0.52 | −1.80 - 2.84 | 0.657 |
 Diuretics | 0.01 | −0.16 - 0.17 | 0.945 | −0.98 | −3.25 - 1.30 | 0.396 |
 BMQ-Specific Concerns | −0.12 | −0.25 - 0.005 | 0.059 | −0.72 | −2.38 - 0.93 | 0.388 |
 BMQ-Specific Necessity | 0.14 | 0.021–0.27 | 0.022 | −0.05 | −1.38 - 1.27 | 0.936 |